The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

John K. Chan, Chunqiao Tian, Joshua P. Kesterson, Michael Richardson, Ken Lin, Krishnansu S. Tewari, Thomas J. Herzog, Daniel S. Kapp, Bradley J. Monk, Yovanni Casablanca, Parviz Hanjani, Robert M. Wenham, Joan L. Walker, Leah McNally, Larry J. Copeland, Sharon E. Robertson, Samuel S. Lentz, Nick M. Spirtos, Jeffery G. Bell